Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Short Interest Up 428.1% in December

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 63,900 shares, an increase of 428.1% from the December 15th total of 12,100 shares. Based on an average trading volume of 124,300 shares, the short-interest ratio is currently 0.5 days.

Fresenius SE & Co. KGaA Price Performance

OTCMKTS:FSNUY traded up $0.10 during trading hours on Tuesday, hitting $8.99. 120,195 shares of the stock traded hands, compared to its average volume of 126,835. The company has a market cap of $20.08 billion, a price-to-earnings ratio of 12.36 and a beta of 1.02. The company has a quick ratio of 1.05, a current ratio of 1.36 and a debt-to-equity ratio of 0.57. The stock has a 50 day moving average price of $8.87 and a 200 day moving average price of $8.89. Fresenius SE & Co. KGaA has a 1 year low of $6.57 and a 1 year high of $9.78.

Wall Street Analysts Forecast Growth

Separately, Citigroup upgraded shares of Fresenius SE & Co. KGaA to a “strong-buy” rating in a report on Friday, October 25th.

About Fresenius SE & Co. KGaA

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.